| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gharib Samir M. | PRESIDENT AND CFO | C/O SPRUCE BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO | /s/ Samir Gharib | 22 Oct 2025 | 0001533302 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SPRB | Common Stock | Options Exercise | $0 | +2,053 | +44% | $0.000000 | 6,727 | 20 Oct 2025 | Direct | F1, F2 |
| transaction | SPRB | Common Stock | Tax liability | $97,934 | -661 | -9.8% | $148.16 | 6,066 | 20 Oct 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SPRB | Restricted Stock Units | Award | $0 | +2,053 | $0.000000 | 2,053 | 20 Oct 2025 | Common Stock | 2,053 | $0.000000 | Direct | F1, F2 | |
| transaction | SPRB | Restricted Stock Units | Options Exercise | $0 | -2,053 | -100% | $0.000000 | 0 | 20 Oct 2025 | Common Stock | 2,053 | $0.000000 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | On March 14, 2024, the Reporting Person was granted 2,053 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 661 shares were withheld for taxes, resulting in a net issuance of 1,392 shares. |
| F2 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of SPRB common stock. |